μsmin® Plus is an innovative diosmin formulation (>80% pure diosmin and 90% total flavonoids) derived from hesperidin found in bitter orange (Citrus aurantium L) that demonstrates enhanced absorption and bioavailability compared to standard micronized diosmin.
In a double-blind, crossover study, smin Plus showed greater plasma concentration and 9.4 times greater bioavailability compared to standard micronized diosmin.
Today Giellepi is pleased to announce the publication of a new clinical study on smin® Plus (Microsmin Plus), titled “Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial”. The results published in Nutrients further strengthen smin® Plus’ superiority in the diosmin marketplace showing dramatic improvements in leg circumference, quality of life (QOL), leg pain and common symptoms associated to Chronic Venous Disease (CVD).
In t